Infants Pain Relief Dye-Free

Description

Acetaminophen is formulated as a liquid dosage form containing 160 mg of acetaminophen per 5 mL. This preparation is designed as a pain reliever and fever reducer, suitable for children aged 2 to 3 years. The product is alcohol-free, aspirin-free, and ibuprofen-free, ensuring it is appropriate for sensitive populations. It is also dye-free and features a cherry flavor to enhance palatability. The total volume of the product is 2 fluid ounces (60 mL).

Uses and Indications

This drug is indicated for the temporary reduction of fever. It also provides relief from minor aches and pains associated with various conditions, including the common cold, sore throat, influenza, toothache, and headache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in pediatric patients, and specific dosing instructions must be followed to ensure safety and efficacy. Prior to administration, the product should be shaken well. Only the enclosed dosing syringe should be utilized for accurate measurement.

To determine the appropriate dose, healthcare professionals should refer to the dosage chart provided below:

• For patients weighing under 24 lbs (under 2 years of age), the dose should be determined by consulting a physician.

• For patients weighing between 24-35 lbs (ages 2-3 years), the recommended dose is 5 mL.

The administration technique involves removing the cap from the bottle and inserting the dosing syringe. The bottle should be inverted to draw the liquid to the prescribed level. The liquid should then be dispensed slowly into the child’s mouth, directed towards the inner cheek to facilitate swallowing.

Dosing may be repeated every 4 hours as needed; however, it is imperative not to exceed 5 doses within a 24-hour period. After use, the cap must be replaced tightly to maintain child resistance, and the dosing syringe should be thoroughly cleaned before returning it to the box.

Healthcare professionals are reminded to adhere strictly to the dosing guidelines and to avoid exceeding the recommended dosage to prevent the risk of overdose.

Contraindications

Use of this product is contraindicated in the following situations:

• Concurrent use with any other drug containing acetaminophen, whether prescription or non-prescription, due to the risk of acetaminophen overdose.

• In patients with a known allergy to acetaminophen or any of the inactive ingredients in this product.

Caution is advised, and a healthcare professional should be consulted prior to use if the patient has liver disease or is taking the anticoagulant warfarin.

Patients must adhere to the recommended dosage to avoid the risk of overdose, which may lead to liver damage. In the event of an overdose, immediate medical assistance or contact with a poison control center is essential, regardless of the presence of symptoms.

Discontinue use and seek medical advice if pain worsens or persists beyond 5 days, fever worsens or lasts more than 3 days, redness or swelling occurs, or if new symptoms develop, as these may indicate a serious condition.

Warnings and Precautions

Severe liver damage may occur in children taking this product, which contains acetaminophen, if they exceed the maximum daily amount of five doses within a 24-hour period or if they are concurrently using other medications that contain acetaminophen. Healthcare professionals should advise parents and caregivers to monitor the total daily intake of acetaminophen from all sources to prevent potential toxicity.

In cases of severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting, it is imperative to consult a physician promptly. These symptoms may indicate a more serious underlying condition that requires medical evaluation.

Before administering this product, healthcare providers should inquire about any existing liver disease in the child. Additionally, it is essential to consult with a doctor or pharmacist if the child is currently taking warfarin or any other anticoagulant, as interactions may increase the risk of adverse effects.

In the event of an overdose, immediate medical assistance should be sought, or a poison control center should be contacted without delay. Rapid intervention is crucial for both adults and children, even if no symptoms are initially apparent.

Healthcare professionals should instruct caregivers to discontinue use and seek medical advice if the child experiences worsening pain that lasts more than five days, a fever that worsens or persists beyond three days, any signs of redness or swelling, or the emergence of new symptoms. These may be indicative of a serious condition that necessitates further investigation and management.

Side Effects

Severe liver damage may occur in patients taking this product containing acetaminophen if they exceed five doses within a 24-hour period, which is the maximum daily amount, or if they use it concurrently with other medications containing acetaminophen. Patients should be advised to consult a doctor promptly if they experience a severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting.

This product should not be used in conjunction with any other drug containing acetaminophen, whether prescription or non-prescription. Patients are encouraged to seek guidance from a doctor or pharmacist if they are uncertain about the use of other medications. Additionally, this product is contraindicated in patients with a known allergy to acetaminophen or any of the inactive ingredients.

Before using this product, patients with liver disease should consult a doctor. Furthermore, patients taking the blood-thinning medication warfarin should also seek advice from a healthcare professional prior to use.

While using this product, it is imperative that patients do not exceed the recommended dose, as doing so may lead to overdose. Patients should discontinue use and consult a doctor if pain worsens or persists for more than five days, if fever worsens or lasts more than three days, if redness or swelling occurs, or if new symptoms arise, as these may indicate a serious condition.

In the event of an overdose, which may result in liver damage, patients should seek medical help or contact a poison control center immediately. Quick medical attention is critical for both adults and children, even if no signs or symptoms are immediately apparent.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. Co-administration may lead to an increased risk of acetaminophen-related hepatotoxicity. Monitoring for signs of liver damage is advised if there is a possibility of overlapping acetaminophen use.

Packaging & NDC

Below are the non-prescription pack sizes of Infants Pain Relief Dye-Free (acteaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 24 lbs (under 2 years) should consult a doctor before use. For children weighing between 24-35 lbs (ages 2-3 years), the recommended dosage is 5 mL.

Severe liver damage may occur if a child exceeds 5 doses in a 24-hour period, which is the maximum daily amount. Parents and caregivers should seek medical advice if a child's sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting.

It is important to consult a doctor before use if the child has liver disease or is taking the blood-thinning medication warfarin. The recommended dosage should not be exceeded, and doses may be repeated every 4 hours as needed, but no more than 5 doses should be administered in a 24-hour period.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy. The prescribing information does not include any statements about contraindications in pregnancy, potential risks to the fetus, dosage modifications, or special precautions for pregnant patients. Healthcare professionals should consider the lack of data when prescribing this medication to women of childbearing potential and weigh the benefits against any potential risks.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk. The effects of this product on a nursing infant are not well studied; therefore, caution is advised.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if they have a history of liver disease. It is critical to adhere to the recommended dosage, as exceeding this may lead to liver damage. Specifically, severe liver damage can occur if a child takes more than five doses within a 24-hour period, which is the maximum daily amount. Additionally, caution is advised when this product is used concurrently with other medications containing acetaminophen, as this combination may also result in severe liver damage. Monitoring of liver function may be warranted in patients with compromised liver function to prevent potential adverse effects.

Overdosage

Taking more than the recommended dose of the medication may lead to significant liver damage. In the event of an overdose, it is imperative to seek medical assistance immediately or contact a poison control center. Prompt medical intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms of overdose.

Healthcare professionals should be vigilant in monitoring patients for any potential symptoms associated with overdose, although specific symptoms are not detailed in the provided information. The emphasis on rapid response underscores the importance of early intervention to mitigate the risk of serious complications.

In summary, any suspected overdose should be treated as a medical emergency, necessitating immediate action to ensure patient safety and optimal outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to communicate the risks associated with overdose, emphasizing that taking more than the recommended dose may lead to liver damage. In the event of an overdose, patients should seek medical help or contact a poison control center immediately, as prompt medical attention is crucial for both adults and children, even if no signs or symptoms are apparent.

Providers should stress the importance of adhering to the recommended dosage and inform patients not to exceed this limit. Patients should be instructed to discontinue use and consult a doctor if they experience any of the following: worsening pain that lasts more than 5 days, worsening fever that persists for more than 3 days, the presence of redness or swelling, or the emergence of new symptoms. These may indicate a serious underlying condition that requires medical evaluation.

Additionally, healthcare providers should recommend that patients consult a doctor before using this medication if their child has liver disease. It is also advisable for patients to speak with a doctor or pharmacist prior to use if their child is currently taking the blood-thinning medication warfarin, to ensure safety and avoid potential interactions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature limits to prevent degradation.

Additional Clinical Information

The medication is administered orally, with a recommended repeat dose every 4 hours as needed, not to exceed 5 doses within a 24-hour period. Clinicians should counsel patients to keep the medication out of reach of children and to seek immediate medical assistance or contact a poison control center in the event of an overdose, as prompt attention is crucial for both adults and children, regardless of the presence of symptoms.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Infants Pain Relief Dye-Free, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)